Selinexor, Daratumumab, and Dexamethasone (XDd) for Light-Chain Cardiac Amyloidosis

NCT07743957 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
63
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Beijing Anzhen Hospital